Global Tobacco Control Research
Overview
The Center for Global Health (CGH) leads international research for global tobacco control with the goal of reducing related cancers and other diseases worldwide.
Impact
Tobacco use is a leading cause of preventable cancer mortality worldwide, responsible for about 25% of cancer deaths and 70% of lung cancer deaths.
While tobacco use and related mortality has been declining in many high-income countries, this trend does not extend to many low- and middle-income countries (LMICs), where 84% of the world’s 1.3 billion current smokers reside. While a large body of tobacco control research has been generated in high-income countries, this work is only partly applicable to the evolving social, economic, and cultural climate of many LMICs. Expanding tobacco control research and research capacity in LMICs is crucial to reducing tobacco use and cancer rates worldwide.
Tobacco Control Research Funding
Since 2000, NCI has supported grants to conduct research in more than 50 countries to study the use and characteristics of diverse tobacco products, evaluate low-cost tobacco cessation interventions, and assess tobacco control policies in distinct environments. Most recently, CGH has supported tobacco cessation interventions tailored to HIV-positive populations, including those with comorbidities such as tuberculosis, in low-resource settings. CGH supports a portfolio of tobacco control research in LMICs, including studying the implementation of evidence-based tobacco control policies and cessation interventions in LMICs. CGH also works with the Fogarty International Center and other NIH Institutes and Centers to support tobacco control research in LMICs through multiple funding mechanisms.
See more information about NCI's tobacco and HIV research.
See current CGH funding opportunities for global cancer research.
See NCI tobacco control funding opportunities that may be open to international applications.
Funded Grants for Global Tobacco Control
PI Name | Organization Name | Project Title | Grant Number |
---|---|---|---|
Glorian C. Sorensen | Dana-Farber Cancer Inst | Disseminating an Evidence-Based Tobacco Control intervention for School Teachers in India | R01CA200691 |
Ritesh Mistry | University of Michigan at Ann Arbor | Longitudinal Study of Adolescent Tobacco Use and Tobacco Control Policy in India | R01CA201415 |
Seth Himelhoch | University of Maryland at Baltimore | Optimizing Smoking Cessation Interventions for PLWH in Nairobi, Kenya | R01CA225419 |
Lisa Quintiliani | Boston Medical Center | Quit for Life (QFL): Smoking Cessation Among Chinese Smokers Living with HIV | R21CA243835 |
Donna Shelley | New York University | Implementing Tobacco Use Treatment in HIV Clinics in Vietnam | R01CA240481 |
Kasisomayajula Viswanath | Dana-Farber Cancer Inst | Adapting and evaluating a brief advice tobacco intervention in high-reach, low-resource settings in India | R01CA230355 |
Heather Wipfli | University of Southern California | Quit4Life+: Adapting and Evaluating a Phone-Based Tobacco Use Cessation Program for People Living with HIV in Uganda and Zambia | U01CA261624 |
Damon Vidrine | H. Lee Moffitt Cancer Ctr & Res Inst | Ending Tobacco Use through Interactive Tailored Messaging for Cambodian People Living with HIV/AIDS (EndIT) | U01CA261598 |
Rajani Sadasivam | Univ of Massachusetts Med Sch Worcester | mHealth Messaging to Motivate Quitline use and Quitting among Persons Living with HIV in Vietnam (M2Q2-HIV) | U01CA261604 |
Jonathan Golub | Johns Hopkins University | Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness | U01CA261626 |
Stella Bialous | University of California, San Francisco | Integrating Tobacco Use Cessation Into HIV Care and Treatment in Ministry of Health Facilities in Kisumu County Kenya | U01CA261620 |
Gina Kruse | Massachusetts General Hospital | Varenicline and mobile behavioral assistance for tobacco cessation in HIV care in India | U01CA261614 |
How to Connect
For information, please contact Dr. Margarita Correa-Méndez or Dr. Mark Parascandola.
Helpful Tools
NCI established the Tobacco Control Monograph Series to provide ongoing and timely information about emerging public health issues in smoking and tobacco use control. NCI partnered with the World Health Organization to develop Monograph 21: The Economics of Tobacco and Tobacco Control, which examines the current research and evidence base surrounding the economics of tobacco control.
For more information on NCI supported tobacco control research programs, visit the Division of Cancer Control and Population Sciences Tobacco Control Research Branch.